MedAvail Holdings, Inc. MDVLQ

0.00 0.00 NaN as of 24 Sep
Market cap
$2.9M
P/E
0.0×
Older periods Sep '22 Dec '22 Mar '23 Jun '23
ROE

+8 more TTM periods

(157.29%) (238.69%) (962.98%) (164.77%)
ROA
(96.46%) (133.61%) (163.78%) (111.18%)
ROIC
(154.51%) (204.18%) 0.00% (291.50%)
Return on Tangible Assets
(127.02%) (204.81%) (184.22%) (194.70%)
Average Days of Receivables
42.23 3.42 1.74 2.46
Free Cash Flow per Share
(34.10) (37.98) (25.23) (17.93)
Free Cash Flow
(54.58) (49.97) (40.50) (32.23)
Capital Expenditures
(2.96) (2.30) (0.89) (0.69)
Piotroski F-Score
3.00 4.00 5.00 5.00
Other line items
Cash ROIC
(74.12%) (123.96%) (156.48%) (79.26%)
Accounts Receivable Turnover
11.72 54.12 44.46 36.59
Accounts Payable Turnover
4.03 24.60 8.65 22.16
Inventory Turnover
3.43 6.37 5.91 5.18
Average Days of Payables
40.06 7.37 8.04 7.15
Days of Inventory on Hand
127.82 79.41 77.92 90.38
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
4.62% 2.59% 2.38% 2.21%
Selling, General and Administrative Expense of Revenue
134.55% 74.20% 73.13% 71.93%
Share Based Compensation of Revenue
10.22% 5.33% 5.41% 4.89%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.05 1.00 0.76 0.69
Depreciation/Fixed assets
0.66 11.22 6.59 6.81
Capex/Depreciation
(0.71) (0.47) (0.17) (0.14)
Revenue per Share
12.21 32.77 27.07 24.10
Operating CF per Share
(32.25) (36.23) (24.67) (17.54)
Capex per Share
(1.85) (1.75) (0.55) (0.39)
Capex to Sales
0.15 0.05 0.02 0.02
Net Profit Margin
(251.53%) (110.45%) (119.46%) (106.16%)

Fold the line items

Columns are period end dates